The regulation and functions of Group 1 CD1-restricted T cells
第 1 组 CD1 限制性 T 细胞的调节和功能
基本信息
- 批准号:10779737
- 负责人:
- 金额:$ 66.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-20 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAffectAntigen PresentationAntigen-Presenting CellsAntigensApolipoprotein EAtherosclerosisAttenuatedAutoimmune DiseasesBone MarrowCD1 AntigensCell CompartmentationCellsCellular Metabolic ProcessCharacteristicsChimera organismChronicChronic PhaseClone CellsCommunicable DiseasesDataDevelopmentDietDiseaseExhibitsFamilyGene Expression ProfileGeneral PopulationGenerationsGenetic TranscriptionGrowthHIVHealthHelper-Inducer T-LymphocyteHigh Fat DietHumanHyperlipidemiaImmune responseImmunityIn VitroIndividualInfectionInflammationKineticsLipidsMaintenanceMediatingMemoryModelingMolecularMolecular ProfilingMusMycobacterium tuberculosisMycolic AcidPathogenicityPathway interactionsPeptidesPhenotypePhospholipidsPlayPopulationPropertyPsoriasisPulmonary InflammationRegulationRoleSignal TransductionSkinSpecificityT cell responseT memory cellT-LymphocyteT-Lymphocyte SubsetsThymus GlandTransgenic MiceTransgenic ModelTuberculosisVaccinatedVaccinationWorkantigen-specific T cellsautoreactive T cellautoreactivitycomorbidityfeedingglucose mycolatein vivoinsightmembermicrobialmouse modelnanoparticlenovelresponsetranscriptometuberculosis immunityvaccine development
项目摘要
PROJECT SUMMARY
Group 1 CD1-restricted T cells are members of the unconventional T cell family that recognize self- and
microbial lipid antigens presented by CD1a, CD1b, and CD1c molecules. Group 1 CD1-restricted T cells
have been implicated to play critical roles in various autoimmune and infectious diseases, in particular
Mycobacterium tuberculosis (Mtb) infection. While group 1 CD1-restricted T cells represent a substantial
part of the T cell repertoire in humans, further understanding of their in vivo function and regulation in
immune response has been stymied by the lack of group 1 CD1 expression in mice. We have previously
generated a transgenic mouse model possessing the entire human group 1 CD1 locus (hCD1Tg) and TCR
transgenic mouse models with Mtb lipid and self-lipid specificity. We demonstrated that both mycolic acid
(MA)-specific and self-lipid-specific CD1b-restricted T cells confers protection against Mtb infection. In
addition, chronic activation of CD1b autoreactive T cells can lead to the development of psoriasis-like skin
inflammation in an ApoE-deficient mouse model of hyperlipidemia. As hyperlipidemia is a common condition
in HIV-infected individuals and the general population, we aim to further understand how it may affect the
function of group 1 CD1-restricted T cells during infection using Mtb infection as a model. In Aim 1, TCR
transgenic mouse models in hCD1Tg/LDLR-/- background will be used to determine the impact of diet-
induced hyperlipidemia on self- and microbial lipid-specific T cells and elucidate the molecular and cellular
mechanisms mediate such effect. The impact of hyperlipidemia on the polyclonal group 1 CD1-restricted T
cell responses to Mtb infection will also be determined by comparing bacterial burden, lung inflammation,
and magnitude of autoreactive and Mtb lipid-specific T cell responses in Mtb-infected hCD1Tg/LDLR-/- mice
with or without hyperlipidemia. While peptide-specific T cells are known to have distinct effector and memory
phenotypes, the properties of memory group 1 CD1-restricted T cells remain elusive. In Aim 2, we will
determine functional properties and protective mechanism of memory MA/CD1b-specific T cells generated
in mice vaccinated with MA containing nanoparticle (MA-NP). To identify common features associated with
Mtb-lipid specific memory T cells, we will compare memory MA/CD1b-specific T cells to glucose
monomycolate/CD1b-specific T cells, isolated from a novel TCR transgenic mouse model expressing a
conserved germline-encoded mycolyl lipid-reactive (GEM) TCR. Lasty, the transcriptional and functional
properties of memory MA/CD1b-specific T cells elicited by two vaccination approaches, MA-NP and an
attenuated Mtb strain, will be compared and their response to subsequent challenge with Mtb will be
evaluated. Collectively, these studies will pave way to better understanding of the role of lipid-specific T
cells in various infectious disease in a relevant comorbidity condition.
项目摘要
第1组CD 1限制性T细胞是非常规T细胞家族的成员,其识别自身免疫细胞和非免疫细胞。
由CD 1a、CD 1b和CD 1c分子呈递的微生物脂质抗原。第1组CD 1限制性T细胞
被认为在各种自身免疫性和传染性疾病中发挥着关键作用,特别是
结核分枝杆菌(Mtb)感染。虽然第1组CD 1-限制性T细胞代表了大量的
人类T细胞库的一部分,进一步了解它们在体内的功能和调节,
免疫应答因小鼠中缺乏组1CD 1表达而受阻。我们先前已经
产生了具有完整的人组1 CD 1基因座(hCD 1 Tg)和TCR的转基因小鼠模型
具有Mtb脂质和自身脂质特异性的转基因小鼠模型。我们证明了分枝菌酸
(MA)特异性和自身脂质特异性CD 1b限制性T细胞赋予针对Mtb感染的保护。在
此外,CD 1b自身反应性T细胞的慢性激活可导致银屑病样皮肤的发展
ApoE缺陷型高脂血症小鼠模型中的炎症。由于高脂血症是一种常见的疾病,
在艾滋病毒感染者和一般人群中,我们的目标是进一步了解它如何影响
使用Mtb感染作为模型,在感染期间第1组CD 1限制性T细胞的功能。在目标1中,TCR
将使用hCD 1 Tg/LDLR-/-背景中的转基因小鼠模型来确定饮食-
诱导高脂血症的自身和微生物的脂质特异性T细胞,并阐明分子和细胞
机制介导这种效应。高脂血症对多克隆组1 CD 1-限制性T细胞的影响
对Mtb感染的细胞应答也将通过比较细菌负荷,肺部炎症,
Mtb感染的hCD 1 Tg/LDLR-/-小鼠中自身反应性和Mtb脂质特异性T细胞应答的大小
伴有或不伴有高脂血症。虽然已知肽特异性T细胞具有独特的效应和记忆,
尽管表型不同,记忆组1 CD 1限制性T细胞的特性仍然难以捉摸。在目标2中,我们将
确定记忆MA/CD 1b特异性T细胞的功能特性和保护机制
在用含MA的纳米颗粒(MA-NP)接种的小鼠中。要识别与以下各项相关的共同特征,请执行以下操作
Mtb-脂质特异性记忆T细胞,我们将比较记忆MA/CD 1b特异性T细胞与葡萄糖
单霉菌酸盐/CD 1b特异性T细胞,分离自表达单霉菌酸盐/CD 1b特异性T细胞的新型TCR转基因小鼠模型。
保守的种系编码的分枝菌酰脂质反应性(GEM)TCR。最后,转录和功能
通过两种疫苗接种方法,MA-NP和免疫接种方法,
减毒的Mtb菌株,将比较它们对随后用Mtb攻击的反应,
评估。总的来说,这些研究将为更好地理解脂质特异性T细胞的作用铺平道路。
细胞在各种感染性疾病的相关并发症条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chyung-Ru Wang其他文献
Chyung-Ru Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chyung-Ru Wang', 18)}}的其他基金
A new mouse model to study the function of CD1b-restricted germline encoded, mycolyl lipid-reactive (GEM) T cells
一种新的小鼠模型,用于研究 CD1b 限制的种系编码的菌基脂质反应性 (GEM) T 细胞的功能
- 批准号:
10727275 - 财政年份:2023
- 资助金额:
$ 66.57万 - 项目类别:
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection
非经典 MHC I 类分子在结核分枝杆菌感染免疫反应中的作用
- 批准号:
10402266 - 财政年份:2018
- 资助金额:
$ 66.57万 - 项目类别:
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection
非经典 MHC I 类分子在结核分枝杆菌感染免疫反应中的作用
- 批准号:
9918253 - 财政年份:2018
- 资助金额:
$ 66.57万 - 项目类别:
Development of Lipid-based Nanoparticle Vaccines Against Mycobacterium tuberculosis
抗结核分枝杆菌脂质纳米颗粒疫苗的研制
- 批准号:
9298853 - 财政年份:2017
- 资助金额:
$ 66.57万 - 项目类别:
The Role of Group 1 CD1-Restricted T Cells in Atherosclerosis
第 1 组 CD1 限制性 T 细胞在动脉粥样硬化中的作用
- 批准号:
8603279 - 财政年份:2013
- 资助金额:
$ 66.57万 - 项目类别:
The Role of Group 1 CD1-Restricted T Cells in Atherosclerosis
第 1 组 CD1 限制性 T 细胞在动脉粥样硬化中的作用
- 批准号:
8451723 - 财政年份:2013
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
6828264 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
7152581 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
7994164 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
Group 1 CD1 in Infectious Disease and T Cell Development
第 1 组 CD1 在传染病和 T 细胞发育中的作用
- 批准号:
7650923 - 财政年份:2003
- 资助金额:
$ 66.57万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 66.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 66.57万 - 项目类别:
Operating Grants














{{item.name}}会员




